Nanomedicine company ViaNautis has taken a 10,825 sq ft laboratory and office space at Howard Group’s Unity Campus in Cambridge.
The ground-breaking firm, a spin-out from University College, London, which works at the forefront of genetic therapies, has signed a 10-year lease on the first floor space in the Cadence building – the third and final new laboratory building on the park.
Howard Group is currently managing the fit-out.
Howard Group chief executive Nicholas Bewes said: “We warmly welcome ViaNautis to Unity Campus. The company’s commitment to advancing the field of gene therapy for the development of treatments for people with cystic fibrosis and CNS is admirable and we wish them every success in their pioneering work.”
ViaNautis chief executive Dr Fran Crawford said: “Moving to this state-of-the-art laboratory and associated offices is representative of ViaNautis’ growth trajectory. We are delighted to be expanding into these new premises which we hope will provide an inspiring workplace for our existing and future talent.”
The letting follows Welbeck Health Partners’ lease of the Orion Building and Domainex’s occupancy of the Sigma Building earlier this year.
The ground and second floors – a total of 20,000 sq ft – remain available in Cadence which has a 60/40 lab-office split in a BREEAM Excellent building.
Savills and JLL are marketing the space.
© Eastern Echo (powered by ukpropertyforums.com).
Sign up to receive our weekly free journal, The Forum here.
